048410 — Hyundai Bioscience Co Cashflow Statement
0.000.00%
- KR₩482bn
- KR₩453bn
- KR₩15bn
Annual cashflow statement for Hyundai Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8,607 | -20,051 | -15,807 | -14,499 | -6,930 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4,520 | 10,974 | -4,516 | 5,252 | 8,094 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 7,811 | 5,835 | 1,997 | 1,804 | 459 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 7,502 | -538 | -16,544 | -6,008 | 2,257 |
| Capital Expenditures | -25,204 | -3,762 | -1,544 | -588 | -2,170 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1,626 | -8,597 | 10,061 | 5,765 | -17,571 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -26,831 | -12,359 | 8,518 | 5,177 | -19,740 |
| Financing Cash Flow Items | -867 | -210 | -229 | -289 | -435 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 32,951 | 2,994 | 1,673 | -58 | 19,190 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13,660 | -10,026 | -6,456 | -921 | 1,845 |